OOIR: Observatory of International Research

Papers

(The H4-Index of Nature Reviews Neurology is 59. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Transmembrane protein interacts with α-synuclein to confer risk of PD	484
Lymphatic propagation of α-synuclein	474
Promising results for antisense RNA therapy in mouse models of diffuse midline glioma	405
Brain stimulation aids walking after spinal injury	354
Reply to ‘Perils and pitfalls of near-death experience research’	338
ANA2025 marks important milestones for the ANA and NINDS	337
Genetic insights from Parkinson disease in African and African admixed populations	296
Neural cell state shifts and fate loss in ageing and age-related diseases	275
Nociceptive action of calcitonin gene-related peptide in the trigeminovascular system	259
Global synergistic actions to improve brain health for human development	236
Deciphering nociplastic pain: clinical features, risk factors and potential mechanisms	218
Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications	206
CD11c+ macrophages mediate brain-to-gut α-synuclein trafficking	195
Disease-specific modifications of tau protein	188
Continuous levodopa production by an artificial enzyme	185
TREM2 mediates phagocytosis in glioblastoma	183
SEQUINS — a new initiative to address disparities in neurology	175
Nir Giladi (1955–2024)	173
Spinal muscular atrophy treatment in utero	172
Rapidly progressive dementias — leukodystrophies as a potentially treatable cause	172
Gut macrophages involved in Parkinson disease pathogenesis	164
Mitochondrial DNA instability in Huntington disease	160
Imperatives and co-benefits of research into climate change and neurological disease	150
The role of the gut microbiota in multiple sclerosis	149
The Digitized Memory Clinic	144

Psychosis-causing lesions mapped to a hippocampal circuit	120
The impact of rare genetic variants on Alzheimer disease	120
Ultrasound lets gene therapy into the brain	117
Amyloid plaques: hotspots for microglial turnover	116
Brain volume is associated with cognition in MS	116
Challenges of combining multimodal data in assessment of people with traumatic brain injury	114
MRI-based deep learning for TLE diagnosis	106
The challenges of anti-tau therapeutics in Alzheimer disease	104
Motor neuron disease in Africa: a critical appraisal of the literature	102
The World Brain Health Forum: breaking silos for co-ordinated action	98
Gene therapy for seizures in focal cortical dysplasia	97
Diversity, equity and inclusion in neurology	94
First trials test targeting of α-synuclein for Parkinson disease	93
Implications of AD plasma and PET biomarker discordance	88
Precision neuroimmunology in multiple sclerosis — the horizon is near	87
Parkinson disease pathology can originate in the kidney	87
Author Correction: Viral pathogens increase risk of neurodegenerative disease	86
Neuroinflammation predicts cognitive decline in FTD	85
Implementation of the 2024 revision of the McDonald criteria for multiple sclerosis	84
Management of freezing of gait — mechanism-based practical recommendations	81
Neurological care for LGBT+ people	77
The noradrenergic subtype of Parkinson disease: from animal models to clinical practice	76
Low-field MRI for equitable epilepsy diagnosis in resource-limited settings	74
Chromosome 21 gene DSCAM drives Down syndrome phenotypes	71
α-Synuclein pathology as a target in neurodegenerative diseases	71
Neurosteroids alleviate seizures in rats	70
Glymphatic dysfunction in PD clinical progression	68
A new biological classification for Parkinson disease	65
Ultrasound ablation treatment for PD	65
Addressing disparities in neurology by building the workforce in LMICs	65
Thalamic inflammation — a therapeutic target for brain injury?	63
Food is brain medicine — relevance and translation to neurology	61
Skull bone marrow changes in multiple sclerosis	60
Spinal cord stimulation for the treatment of chronic pain	60
Newborn screening for spinal muscular atrophy: time is motor neuron	59